BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 866 filers reported holding BAXTER INTL INC in Q3 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $5,272 | +2.8% | 136 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $5,130 | -17.0% | 136 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $6,178 | +12.6% | 136 | +0.7% | 0.00% | 0.0% |
Q1 2023 | $5,485 | -20.3% | 135 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $6,878 | -1.7% | 135 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $7,000 | -22.2% | 135 | +0.7% | 0.00% | -50.0% |
Q2 2022 | $9,000 | -10.0% | 134 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $10,000 | -94.0% | 134 | -93.2% | 0.00% | -92.3% |
Q4 2021 | $168,000 | +32.3% | 1,959 | +23.7% | 0.03% | +23.8% |
Q3 2021 | $127,000 | 0.0% | 1,584 | 0.0% | 0.02% | 0.0% |
Q2 2021 | $127,000 | +5.0% | 1,584 | +10.5% | 0.02% | 0.0% |
Q1 2021 | $121,000 | +5.2% | 1,434 | +0.1% | 0.02% | -4.5% |
Q4 2020 | $115,000 | +945.5% | 1,433 | +977.4% | 0.02% | +1000.0% |
Q3 2020 | $11,000 | 0.0% | 133 | 0.0% | 0.00% | -33.3% |
Q2 2020 | $11,000 | 0.0% | 133 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $11,000 | 0.0% | 133 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $11,000 | +175.0% | 133 | +166.0% | 0.00% | +200.0% |
Q3 2019 | $4,000 | -63.6% | 50 | -62.4% | 0.00% | -66.7% |
Q2 2019 | $11,000 | -21.4% | 133 | -38.4% | 0.00% | -25.0% |
Q1 2018 | $14,000 | +27.3% | 216 | +30.1% | 0.00% | 0.0% |
Q4 2017 | $11,000 | +10.0% | 166 | 0.0% | 0.00% | +33.3% |
Q3 2017 | $10,000 | 0.0% | 166 | 0.0% | 0.00% | -25.0% |
Q2 2017 | $10,000 | +11.1% | 166 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $9,000 | -30.8% | 166 | -43.2% | 0.00% | -20.0% |
Q4 2016 | $13,000 | -94.9% | 292 | -94.5% | 0.01% | -95.5% |
Q3 2016 | $254,000 | +5.0% | 5,342 | 0.0% | 0.11% | +0.9% |
Q2 2016 | $242,000 | +1916.7% | 5,342 | +1729.5% | 0.11% | +1485.7% |
Q1 2016 | $12,000 | +9.1% | 292 | 0.0% | 0.01% | +16.7% |
Q4 2015 | $11,000 | +10.0% | 292 | 0.0% | 0.01% | 0.0% |
Q3 2015 | $10,000 | -50.0% | 292 | 0.0% | 0.01% | -50.0% |
Q2 2015 | $20,000 | -23.1% | 292 | -22.1% | 0.01% | -25.0% |
Q1 2015 | $26,000 | -3.7% | 375 | 0.0% | 0.02% | -15.8% |
Q4 2014 | $27,000 | 0.0% | 375 | 0.0% | 0.02% | -9.5% |
Q3 2014 | $27,000 | +200.0% | 375 | +197.6% | 0.02% | +200.0% |
Q2 2014 | $9,000 | 0.0% | 126 | 0.0% | 0.01% | -12.5% |
Q1 2014 | $9,000 | -50.0% | 126 | -50.0% | 0.01% | -46.7% |
Q4 2013 | $18,000 | +125.0% | 252 | +100.0% | 0.02% | +87.5% |
Q3 2013 | $8,000 | – | 126 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |